ALL
Pharma in China
Pharma Experts
Market News
Products Guide
Brand Story
-
BiomX collaborates with Boehringer Ingelheim for microbiome-based biomarkers for IBD
September 03, 2020The terms of the collaboration also include an option for Boehringer Ingelheim to negotiate an exclusive right to biomarkers discovered utilising the XMarker platform. -
BiomX Completes In-house Phage Manufacturing Facility
September 04, 2019BiomX Ltd., a microbiome company developing both natural and engineered phage therapies, has completed construction of a new state-of-the-art manufacturing facility. -
BiomX raises funds to advance drug candidates for acne and IBD
February 22, 2019Israeli drug discovery firm BiomX has raised funds in a series B round to advance its lead acne and inflammatory bowel disease (IBD) drug programmes to the clinic..... -
BiomX Enters Collaboration with Johnson & Johnson Innovation for Discovery of Microbiome-based Biomarkers for IBD
December 13, 2018BiomX Ltd., a microbiome company developing customized phage therapies, today announced that it has entered into a collaboration with Janssen Research & Development... -
BiomX in-licenses novel bacterial targets for IBD treatment
February 01, 2018BX002 offers a groundbreaking approach for treating IBD as it targets a possible underlying cause for the disease
Pharma Sources Insight January 2025
